Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Accenture
Fish and Richardson
Chubb
Dow
US Army
Johnson and Johnson
Healthtrust
McKinsey

Generated: October 21, 2017

DrugPatentWatch Database Preview

Alkem Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM, and what generic and branded alternatives to ALKEM drugs are available?

ALKEM has twenty-nine approved drugs.

There are seven tentative approvals on ALKEM drugs.

Summary for Applicant: Alkem

US Patents:0
Tradenames:25
Ingredients:25
NDAs:29
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem
AMLODIPINE BESYLATE
amlodipine besylate
TABLET;ORAL078925-003May 4, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL204453-001Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem
AMLODIPINE BESYLATE
amlodipine besylate
TABLET;ORAL078925-002May 4, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065496-002Jun 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
ITRACONAZOLE
itraconazole
CAPSULE;ORAL208591-001Jun 12, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
FESOTERODINE FUMARATE
fesoterodine fumarate
TABLET, EXTENDED RELEASE;ORAL204827-002Dec 10, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL201504-005Feb 12, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL209042-002Aug 14, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
OLANZAPINE
olanzapine
TABLET;ORAL202295-005Oct 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203741-004Jun 24, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
McKinsey
Novartis
Healthtrust
Fuji
Daiichi Sankyo
Express Scripts
Accenture
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot